Latiglutenase as a Treatment for Celiac Disease

NCT03585478 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: Latiglutenase
OTHER: Placebo

Sponsor

Immunogenics, LLC

Collaborators

[object Object]
[object Object]